Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanosilver Fluoride vs SDF for Caries in Primary Teeth
NCT05221749Phase 3Terminated
- Start
- Mar 2022
- Primary completion
- Apr 2022
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nanosilver fluoride in dental caries (2 arms). Primary endpoints: Antibacterial Effect in Active Dental Caries Lesions at 1 month, The Relation Between the Antibacterial Activity and the Caries Activity in Dental Caries Lesions at 1 month and 1 more. Started Mar 2022; status: terminated.
02
Drugs
nanosilver fluoride
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT05221749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05221749.